rs12028832

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_013296.5(GPSM2):​c.557+17A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0146 in 1,611,010 control chromosomes in the GnomAD database, including 403 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 80 hom., cov: 32)
Exomes 𝑓: 0.014 ( 323 hom. )

Consequence

GPSM2
NM_013296.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.460

Publications

2 publications found
Variant links:
Genes affected
GPSM2 (HGNC:29501): (G protein signaling modulator 2) The protein encoded by this gene belongs to a family of proteins that modulate activation of G proteins, which transduce extracellular signals received by cell surface receptors into integrated cellular responses. The N-terminal half of this protein contains 10 copies of leu-gly-asn (LGN) repeat, and the C-terminal half contains 4 GoLoco motifs, which are involved in guanine nucleotide exchange. This protein may play a role in neuroblast division and in the development of normal hearing. Mutations in this gene are associated with autosomal recessive nonsyndromic deafness (DFNB82). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
CLCC1 (HGNC:29675): (chloride channel CLIC like 1) Predicted to enable chloride channel activity. Predicted to be involved in chloride transport. Located in endoplasmic reticulum and mitochondria-associated endoplasmic reticulum membrane. Implicated in retinitis pigmentosa 32. [provided by Alliance of Genome Resources, Apr 2022]
AKNAD1 (HGNC:28398): (AKNA domain containing 1) This gene encodes a protein which contains a domain found in an AT-hook-containing transcription factor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-108898118-A-G is Benign according to our data. Variant chr1-108898118-A-G is described in ClinVar as [Benign]. Clinvar id is 260281.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0537 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPSM2NM_013296.5 linkc.557+17A>G intron_variant Intron 5 of 14 ENST00000264126.9 NP_037428.3 P81274A0A024R0F8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPSM2ENST00000264126.9 linkc.557+17A>G intron_variant Intron 5 of 14 1 NM_013296.5 ENSP00000264126.3 P81274

Frequencies

GnomAD3 genomes
AF:
0.0246
AC:
3750
AN:
152186
Hom.:
77
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0551
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0167
Gnomad ASJ
AF:
0.0288
Gnomad EAS
AF:
0.0133
Gnomad SAS
AF:
0.0586
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.00998
Gnomad OTH
AF:
0.0229
GnomAD2 exomes
AF:
0.0188
AC:
4718
AN:
251082
AF XY:
0.0199
show subpopulations
Gnomad AFR exome
AF:
0.0554
Gnomad AMR exome
AF:
0.00980
Gnomad ASJ exome
AF:
0.0276
Gnomad EAS exome
AF:
0.0171
Gnomad FIN exome
AF:
0.00152
Gnomad NFE exome
AF:
0.0101
Gnomad OTH exome
AF:
0.0184
GnomAD4 exome
AF:
0.0135
AC:
19695
AN:
1458706
Hom.:
323
Cov.:
30
AF XY:
0.0147
AC XY:
10654
AN XY:
725948
show subpopulations
African (AFR)
AF:
0.0571
AC:
1906
AN:
33398
American (AMR)
AF:
0.0109
AC:
489
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0273
AC:
713
AN:
26106
East Asian (EAS)
AF:
0.0155
AC:
614
AN:
39676
South Asian (SAS)
AF:
0.0518
AC:
4462
AN:
86168
European-Finnish (FIN)
AF:
0.00197
AC:
105
AN:
53412
Middle Eastern (MID)
AF:
0.0350
AC:
201
AN:
5750
European-Non Finnish (NFE)
AF:
0.00910
AC:
10096
AN:
1109222
Other (OTH)
AF:
0.0184
AC:
1109
AN:
60256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
942
1885
2827
3770
4712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0248
AC:
3776
AN:
152304
Hom.:
80
Cov.:
32
AF XY:
0.0254
AC XY:
1892
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0556
AC:
2310
AN:
41550
American (AMR)
AF:
0.0167
AC:
255
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0288
AC:
100
AN:
3468
East Asian (EAS)
AF:
0.0133
AC:
69
AN:
5190
South Asian (SAS)
AF:
0.0582
AC:
281
AN:
4828
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10620
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0100
AC:
680
AN:
68026
Other (OTH)
AF:
0.0227
AC:
48
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
186
372
559
745
931
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0163
Hom.:
47
Bravo
AF:
0.0262
Asia WGS
AF:
0.0420
AC:
145
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.9
DANN
Benign
0.56
PhyloP100
-0.46
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12028832; hg19: chr1-109440740; API